Skip to main content

Cephalon, Inc. Under Investor Investigation Over Possible Breaches Of Fiduciary Duty

  • If you purchased shares of Cephalon, Inc. (Public, NASDAQ:CEPH) and currently hold those CEPH shares, and/or if you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

After Cephalon, Inc. disclosed it received a subpoena by the U.S. Postal Service Office of Inspector General in connection with its pain drug Fentora an investigation on behalf of current long term investors over possible breaches of fiduciary duties by certain officers and directors at Cephalon, Inc. was announced. The investigation by a law firm concerns whether certain officers and...



You must register (for free) or login to view the entire investigation.